Schedule 13G ownership disclosure
INTRA-CELLULAR THERAPIES INC
Security class unavailable · CUSIP: 46116X101
Event date: 2020-01-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-20-026631
- Form type
- SC 13G
- Filer
- BB BIOTECH AG
- CIK
- CIK 924223
- Filed
- Feb 06, 2020
- Reporting period
- Jan 30, 2020
- Description
- Schedule 13G beneficial ownership